Credit Suisse’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-1,545,951
| Closed | -$30.1M | – | 3684 |
|
|
2018
Q1 | $30.1M | Sell |
1,545,951
-270,535
| -15% | -$5.26M | 0.03% | 550 |
|
|
2017
Q4 | $30.2M | Buy |
1,816,486
+1,719,764
| +1,778% | +$28.6M | 0.03% | 526 |
|
|
2017
Q3 | $1.96M | Buy |
96,722
+39,456
| +69% | +$801K | ﹤0.01% | 2148 |
|
|
2017
Q2 | $921K | Sell |
57,266
-25,568
| -31% | -$411K | ﹤0.01% | 2404 |
|
|
2017
Q1 | $1.05M | Sell |
82,834
-312,605
| -79% | -$3.96M | ﹤0.01% | 2487 |
|
|
2016
Q4 | $5.24M | Buy |
395,439
+315,022
| +392% | +$4.17M | 0.01% | 1390 |
|
|
2016
Q3 | $1.91M | Sell |
80,417
-27,820
| -26% | -$659K | ﹤0.01% | 2125 |
|
|
2016
Q2 | $3.12M | Buy |
108,237
+55,811
| +106% | +$1.61M | ﹤0.01% | 1788 |
|
|
2016
Q1 | $1.68M | Sell |
52,426
-69,823
| -57% | -$2.24M | ﹤0.01% | 2089 |
|
|
2015
Q4 | $5.23M | Buy |
122,249
+4,460
| +4% | +$191K | 0.01% | 1429 |
|
|
2015
Q3 | $4.15M | Sell |
117,789
-16,819
| -12% | -$592K | 0.01% | 1580 |
|
|
2015
Q2 | $6.18M | Buy |
134,608
+74,245
| +123% | +$3.41M | 0.01% | 1435 |
|
|
2015
Q1 | $2.83M | Buy |
60,363
+8,284
| +16% | +$388K | ﹤0.01% | 1889 |
|
|
2014
Q4 | $1.65M | Sell |
52,079
-31,822
| -38% | -$1.01M | ﹤0.01% | 2391 |
|
|
2014
Q3 | $1.99M | Sell |
83,901
-14,439
| -15% | -$342K | ﹤0.01% | 2169 |
|
|
2014
Q2 | $2.95M | Sell |
98,340
-16,206
| -14% | -$486K | ﹤0.01% | 2063 |
|
|
2014
Q1 | $3.03M | Sell |
114,546
-1,669
| -1% | -$44.1K | ﹤0.01% | 1923 |
|
|
2013
Q4 | $2.92M | Buy |
116,215
+6,579
| +6% | +$165K | ﹤0.01% | 2004 |
|
|
2013
Q3 | $2.24M | Buy |
109,636
+43,777
| +66% | +$896K | ﹤0.01% | 1949 |
|
|
2013
Q2 | $1.31M | Buy |
+65,859
| New | +$1.31M | ﹤0.01% | 2238 |
|